Inhibition of gamma-secretase activity without interfering in Notch signalling decreases inflammatory response in patients with cutaneous leishmaniasis

References

• Bittencourt AL, Barral A. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem Inst Oswaldo Cruz. 1991 Jan–Mar;86(1):51–56.
   PubMed Web of Science ®Google Scholar
• Carvalho LP, Passos S, Bacellar O, et al. Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite Immunol. 2007 May;29(5):251–258.
   Web of Science ®Google Scholar
• Carvalho LP, Passos S, Schriefer A, et al. Protective and pathologic immune responses in human tegumentary leishmaniasis. Front Immunol. 2012;3:301.
   Web of Science ®Google Scholar
• Passos S, Carvalho LP, Costa RS, et al. Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections. J Infect Dis. 2015 Jan 15;211(2):274–282.
   PubMed Web of Science ®Google Scholar
• Santos D, Campos TM, Saldanha M, et al. IL-1beta production by intermediate monocytes is associated with immunopathology in cutaneous leishmaniasis. J Invest Dermatol. 2018 May;138(5):1107–1115.
   PubMed Web of Science ®Google Scholar
• Saldanha MG, Queiroz A, Machado PRL, et al. Characterization of the histopathologic features in patients in the early and late phases of cutaneous leishmaniasis. Am J Trop Med Hyg. 2017 Mar;96(3):645–652.
   PubMed Web of Science ®Google Scholar
• Campos TM, Costa R, Passos S, et al. Cytotoxic activity in cutaneous leishmaniasis. Mem Inst Oswaldo Cruz. 2017 Nov;112(11):733–740.
   Web of Science ®Google Scholar
• Costa RS, Carvalho LP, Campos TM, et al. Early cutaneous leishmaniasis patients infected with Leishmania braziliensis express increased inflammatory responses after antimony therapy. J Infect Dis. 2018 Feb 14;217(5):840–850.
   Web of Science ®Google Scholar
• Machado P, Araujo C, Da Silva AT, et al. Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clin Infect Dis. 2002 Jun 15;34(12):E69–E73.
   Web of Science ®Google Scholar
• Unger A, O'Neal S, Machado PR, et al. Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil. Am J Trop Med Hyg. 2009 Apr;80(4):574–579.
   Web of Science ®Google Scholar
• Wolf Nassif P, Mello TFPDE, Navasconi TR, et al. Safety and efficacy of current alternatives in the topical treatment of cutaneous leishmaniasis: a systematic review. Parasitology. 2017 Jul;144(8):995–1004.
   Web of Science ®Google Scholar
• Novais FO, Carvalho AM, Clark ML, et al. CD8+ t cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production. PLoS Pathog. 2017 Feb;13(2):e1006196.
   PubMed Web of Science ®Google Scholar
• Novais FO, Carvalho LP, Passos S, et al. Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology. J Invest Dermatol. 2015 Jan;135(1):94–101.
   PubMed Web of Science ®Google Scholar
• Lessa HA, Machado P, Lima F, et al. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg. 2001 Aug;65(2):87–89.
   PubMed Web of Science ®Google Scholar
• Carvalho AM, Novais FO, Paixao CS, et al. Glyburide, a NLRP3 inhibitor, decreases inflammatory response and is a candidate to reduce pathology in Leishmania braziliensis infection. J Invest Dermatol. 2020 Jan;140(1):246–249e2.
   Web of Science ®Google Scholar
• Charmoy M, Hurrell BP, Romano A, et al. The Nlrp3 inflammasome, IL-1β, and neutrophil recruitment are required for susceptibility to a nonhealing strain of leishmania major in C57BL/6 mice. Eur J Immunol. 2016 Apr;46(4):897–911.
   PubMed Web of Science ®Google Scholar
• Amsen D, Blander JM, Lee GR, et al. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell. 2004 May 14;117(4):515–526.
   PubMed Web of Science ®Google Scholar
• Robey E, Chang D, Itano A, et al. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell. 1996 Nov 1;87(3):483–492.
   Web of Science ®Google Scholar
• Tanigaki K, Tsuji M, Yamamoto N, et al. Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity. 2004 May;20(5):611–622.
   Web of Science ®Google Scholar
• Washburn T, Schweighoffer E, Gridley T, et al. Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell. 1997 Mar 21;88(6):833–843.
   Web of Science ®Google Scholar
• Andersson ER, Sandberg R, Lendahl U. Notch signaling: simplicity in design, versatility in function. Development. 2011 Sep;138(17):3593–3612.
   PubMed Web of Science ®Google Scholar
• Petit A, Bihel F, Alves da Costa C, et al. New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage. Nat Cell Biol. 2001 May;3(5):507–511.
   Web of Science ®Google Scholar
• Monsalve E, Ruiz-Garcia A, Baladron V, et al. Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity. Eur J Immunol. 2009 Sep;39(9):2556–2570.
   Web of Science ®Google Scholar
• Palaga T, Buranaruk C, Rengpipat S, et al. Notch signaling is activated by TLR stimulation and regulates macrophage functions. Eur J Immunol. 2008 Jan;38(1):174–183.
   Web of Science ®Google Scholar
• Song LL, Peng Y, Yun J, et al. Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene. 2008 Oct 2;27(44):5833–5844.
   Web of Science ®Google Scholar
• Weijzen S, Velders MP, Elmishad AG, et al. The Notch ligand jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. J Immunol. 2002 Oct 15;169(8):4273–4278.
   Web of Science ®Google Scholar
• Auderset F, Coutaz M, Tacchini-Cottier F. The role of Notch in the differentiation of CD4(+) T helper cells. Curr Top Microbiol Immunol. 2012;360:115–134.
   PubMed Web of Science ®Google Scholar
• Rodrigues KM, Oliveira MP, Maretti-Mira AC, et al. Influence of the Notch system in the therapeutic response of American tegumentary leishmaniasis. Br J Dermatol. 2011 Jun;164(6):1228–1234.
   Web of Science ®Google Scholar
• Amorim CF, Novais FO, Nguyen BT, et al. Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis. Sci Transl Med. 2019 Nov 20;11(519):1–9.
   Web of Science ®Google Scholar
• Cupolillo E, Grimaldi G, Jr., Momen H. A general classification of new world leishmania using numerical zymotaxonomy. Am J Trop Med Hyg. 1994 Mar;50(3):296–311.
   Web of Science ®Google Scholar
• Teixeira R, Reed SG, Badaro R, et al. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg. 1986 Jan;35(1):79–85.
   Web of Science ®Google Scholar
• Giudice A, Vendrame C, Bezerra C, et al. Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection. BMC Infect Dis. 2012 Mar 29;12:75.
   PubMed Web of Science ®Google Scholar
• López-López S, Monsalve EM, Romero de Ávila MJ, et al. NOTCH3 signaling is essential for NF-κB activation in TLR-activated macrophages. Sci Rep. 2020 Sep 9;10(1):14839.
   Web of Science ®Google Scholar
• Brito G, Dourado M, Guimarães LH, et al. Oral pentoxifylline associated with pentavalent antimony: a randomized trial for cutaneous leishmaniasis. Am J Trop Med Hyg. 2017 May;96(5):1155–1159.
   PubMed Web of Science ®Google Scholar
• Mikulca JA, Nguyen V, Gajdosik DA, et al. Potential novel targets for Alzheimer pharmacotherapy: II. update on secretase inhibitors and related approaches. J Clin Pharm Ther. 2014 Feb;39(1):25–37.
   PubMed Web of Science ®Google Scholar
• Toyn JH, Ahlijanian MK. Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β. Alzheimers Res Ther. 2014;6(2):14.
   PubMed Web of Science ®Google Scholar
• Campos TM, Novais FO, Saldanha M, et al. Granzyme B produced by natural killer cells enhances inflammatory response and contributes to the immunopathology of cutaneous leishmaniasis. J Infect Dis. 2020 Mar 2;221(6):973–982.
   PubMed Web of Science ®Google Scholar
• Kane MM, Mosser DM. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol. 2001 Jan 15;166(2):1141–1147.
   PubMed Web of Science ®Google Scholar
• Novais FO, Nguyen BT, Beiting DP, et al. Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species. J Infect Dis. 2014 Apr 15;209(8):1288–1296.
   Web of Science ®Google Scholar